As news heats up about Neuralink, Elon Musk's brain-implant company, investors will have questions about Tesla stock.
Elon Musk is known for running Tesla and SpaceX—and for being the world’s richest human—and now he wants to get into your head. His brain-implant company Neuralink is enrolling patients in its first human trial.
The first trial is called PRIME. Medical trials always seem to be named using interesting acronyms. PRIME is short for Precise Robotically IMplanted Brain-Computer Interfacelateral sclerosis, or ALS. What all this has to do with Tesla is an open question. Musk’s non-Tesla activities can, however, impact Tesla investors.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Neuralink: Thousands sign up for Elon Musk’s brain chip human trialInteresting Engineering is a cutting edge, leading community designed for all lovers of engineering, technology and science.
Read more »
PlayStation Consoles Cut Off Twitter/X IntegrationSony is dropping support for Elon Musk's X (aka Twitter) from its PlayStation game consoles.
Read more »
Elon Musk almost needed SFPD wellness check after ‘breakdown,’ getting booed at Dave Chappelle show‘He got to a point where he locked himself in his office, was so upset’ that Twitter employees feared he would hurt himself, the author of a new book says about the billionaire.
Read more »
Elon Musk Will 'Look Into' PlayStation's Removal of Twitter/X on PS5 and PS4Could Musk change Sony's mind before it ditches its native support for X on PS5 and PS4?
Read more »
NFT sales jump to $129M, OpenSea layoffs and Elon Musk slams NFTs: Nifty NewsletterNFT sales volume has consistently increased in the weeks leading up to November, according to data published by Nansen.
Read more »
Elon Musk 'spiraled' after being booed at comedy show, locked himself in office: author“I think he truly cares about his reputation,” “Breaking Twitter” author Ben Mezrich said of the Tesla co-founder in a new interview.
Read more »